Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.
Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model.
Targeting stroma to treat cancers.
Specificity in cancer immunotherapy.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Specificity in cancer immunotherapy.
Specificity in cancer immunotherapy. Semin Immunol. 2008 Oct; 20(5):276-85.
View in:
PubMed
subject areas
Animals
Antigens, Neoplasm
Cancer Vaccines
Glycosylation
Humans
Immunotherapy
Neoplasms
T-Lymphocytes
authors with profiles
Hans Schreiber